Plasma exchange in the treatment of Refsum's disease (heredopathia atactica polyneuritiformis).
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1716665.
- Also identified by PMC identifier 1014432.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Five cases of heredopathia atactica polyneuritiformis (HAP--Refsum's disease) were treated by serial plasma exchanges. In all patients a reduction in calorie intake and body weight had been associated with a rise in plasma phytanic acid, followed by an exacerbation of the ataxia and neuropathy. Lowering the plasma phytanic acid by plasma exchange produced a rapid clinical improvement. The main indication for plasma exchange in HAP is a severe or rapidly worsening clinical condition. A lesser indication is failure of dietary management to reduce a high plasma phytanic acid level.
Medical subject headings
- Plasma Exchange
- Refsum Disease